Guidelines Development Group

The objective of the Guidelines Development Group (GDG) is to develop evidence-based European Guidelines for breast cancer screening and diagnosis for screening and diagnosis.

The GDG will follow the GRADE approach in defining the healthcare question of interest (population of interest, interventions to be compared and patient-relevant outcomes- PICO), synthesizing the evidence and developing the recommendations for the Guidelines. This will be carried out within virtual working environments and in meetings organised every three months.

An external contractor, CCIb –Iberoamerican Cochrane Centre, supports the GDG for their tasks from literature review to drafting of recommendations.

Members and external experts

Mireille Broeders

Mireille Broeders

Department for Health Evidence, Radboud University Nijmegen Medical Center & Dutch Reference Centre for  Screening, Nijmegen, the Netherlands

Dr. Mireille Broeders is a cancer screening epidemiologist with an academic degree in biomedical health sciences. She is an Associate Professor at the Department for Health Evidence, Radboud university medical center, in Nijmegen, the Netherlands. Her research focuses on establishing the impact of cancer screening programmes, in particular screening for breast cancer, and the potential value of moving to risk-based screening regimens. Dr. Broeders has a special interest in observational research designs that can be used in this field of research. As a long-standing member of the National Evaluation Team for Breast Cancer Screening, she is also involved with the evaluation of the long-term benefits and harms of the Dutch nation-wide breast screening programme.

Dr. Broeders further works as scientific supervisor at the Dutch Reference Centre for Screening in Nijmegen. This has broadened her research interests to include e.g. the implementation and evaluation of technological developments in the breast screening programme, pain experience during breast compression and test sets for radiologists. All research projects at the Centre aim at the safeguard and constant improvement of the quality of the breast cancer screening programme.

At a European level, Dr. Broeders contributed, as editor and author, to the European Guidelines for Quality Assurance for Breast Screening and Diagnosis.

Dr. Broeders has been co-leading the EUROSCREEN working group, a European research effort to summarise breast cancer screening service screening outcomes, published as supplement to the Journal of Medical Screening (2012). She has co-authored over 100 papers in peer-reviewed journals.

Declaration of interests